Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Beatriz E. Amendola, Marco Amendola, Naipy Perez, Jesus M. Blanco and Xiaodong Wu
Radiation therapy remains an indispensable tool in palliative care. However, in the past, in order to achieve the results needed, palliative radiation therapy took weeks, a span of time which was often too long for terminal patients to bear. Advances in medical imaging and radiation therapy hardware and software have made possible to deliver high doses of focal radiation using shortened fractionation schemes. These may range from 1 to 5 fractions, targeting only the tumor area with optimized protection of normal tissue, which results in minimal toxicity, less physical demands to the patient and most importantly, more prompt palliative response. A novel radiation therapy technique, called “Stereotactic Radiosurgery” (SRS) or “Stereotactic Body Radiotherapy” (SBRT), originally developed and used as primary modality of treatment for many cancers with curative intent, is becoming an invaluable tool in the palliative care of patients with terminal cancer. In this article, we describe a typical case where SRS/SBRT demonstrates its value and efficacy and discuss present and future applications of this innovative technique in the palliative care of patients with terminal cancers.